Suppr超能文献

评估异基因造血干细胞移植后肠道病毒/鼻病毒呼吸道感染的免疫缺陷评分指数表现。

Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.

机构信息

Department of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.

Department of Hematology, Hospital Universitari I Politècnic la Fe, Valencia, Spain.

出版信息

Transpl Infect Dis. 2020 Aug;22(4):e13301. doi: 10.1111/tid.13301. Epub 2020 May 23.

Abstract

BACKGROUND

Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT).

OBJECTIVE

We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers.

RESULTS

We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant.

CONCLUSIONS

Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.

摘要

背景

肠病毒/鼻病毒(EvRh)是异基因造血干细胞移植(allo-HSCT)受者中呼吸道病毒感染的最常见原因。

目的

我们旨在分析免疫缺陷评分指数(ISI)在预测西班牙两个移植中心于 2013 年 12 月 1 日至 2019 年 12 月 1 日期间连续接受 allo-HSCT 的成年(>16 岁)EvRh 感染患者中,下呼吸道疾病(LRTD)进展和死亡率方面的价值。

结果

我们纳入了 234 例 allo-HSCT 受者,共发生 383 例 EvRh 感染。在 383 例 EvRh 感染中,98 例(25%)发生了 LRTD。多变量逻辑回归分析确定了与 LRTD 进展相关的三个独立因素:IgG<400mg/dL、社区获得性呼吸道病毒(CARV)合并感染和高危 ISI。IgG 水平和 CARV 合并感染纳入 ISI 后,显著提高了其性能,使得接受者操作特征曲线(AUROC)下面积从 0.643 增加到 0.734(P=0.03)。同样,多变量分析确定的与死亡率较高相关的两个条件是高危 ISI 和移植后 6 个月内的 EvRh 感染。

结论

我们的研究结果证实了高危 ISI 对预测 EvRh LRTD 概率和 3 个月总死亡率均有价值。我们还证明,通过纳入其他变量,可以对原始 ISI 进行调整,以提高其性能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验